-
A new Standard DNA damage (SDD) data format
Authors:
J. Schuemann,
A. McNamara,
J. W. Warmenhoven,
N. T. Henthorn,
K. Kirkby,
M. J. Merchant,
S. Ingram,
H. Paganetti,
KD. Held,
J. Ramos-Mendez,
B. Faddegon,
J. Perl,
D. Goodhead,
I. Plante,
H. Rabus,
H. Nettelbeck,
W. Friedland,
P. Kundrat,
A. Ottolenghi,
G. Baiocco,
S. Barbieri,
M. Dingfelder,
S. Incerti,
C. Villagrasa,
M. Bueno
, et al. (26 additional authors not shown)
Abstract:
Our understanding of radiation induced cellular damage has greatly improved over the past decades. Despite this progress, there are still many obstacles to fully understanding how radiation interacts with biologically relevant cellular components to form observable endpoints. One hurdle is the difficulty faced by members of different research groups in directly comparing results. Multiple Monte Ca…
▽ More
Our understanding of radiation induced cellular damage has greatly improved over the past decades. Despite this progress, there are still many obstacles to fully understanding how radiation interacts with biologically relevant cellular components to form observable endpoints. One hurdle is the difficulty faced by members of different research groups in directly comparing results. Multiple Monte Carlo codes have been developed to simulate damage induction at the DNA scale, while at the same time various groups have developed models that describe DNA repair processes with varying levels of detail. These repair models are intrinsically linked to the damage model employed in their development, making it difficult to disentangle systematic effects in either part of the modelling chain. The modelling chain typically consists of track structure Monte Carlo simulations of the physics interactions creating direct damages to the DNA; followed by simulations of the production and initial reactions of chemical species causing indirect damages. After the DNA damage induction, DNA repair models combine the simulated damage patterns with biological models to determine the biological consequences of the damage. We propose a new Standard data format for DNA Damage to unify the interface between the simulation of damage induction and the biological modelling of cell repair processes. Such a standard greatly facilitates inter model comparisons, providing an ideal environment to tease out model assumptions and identify persistent, underlying mechanisms. Through inter model comparisons, this unified standard has the potential to greatly advance our understanding of the underlying mechanisms of radiation induced DNA damage and the resulting observable biological effects.
△ Less
Submitted 11 January, 2022;
originally announced January 2022.
-
Map** the Future of Particle Radiobiology in Europe: The INSPIRE Project
Authors:
N. T. Henthorn,
O. Sokol,
M. Durante,
L. De Marzi,
F. Pouzoulet,
J. Miszczyk,
P. Olko,
S. Brandenburg,
M-J. van Goethem,
L. Barazzuol,
M. Tambas,
J. A. Langendijk,
M. Davidkova,
V. Vondravcek,
E. Bodenstein,
J. Pawelke,
A. Lomax,
D. C. Weber,
A. Dasu,
B. Stenerlow,
P. R. Poulsen,
B. S. Sorensen,
C. Grau,
M. K. Sitarz,
A-C Heuskin
, et al. (5 additional authors not shown)
Abstract:
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimental investigation. The Infrastructure in Proton International Research (INSPIRE) project was created t…
▽ More
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimental investigation. The Infrastructure in Proton International Research (INSPIRE) project was created to provide an infrastructure for European research, unify research efforts on the topic of proton and ion therapy across Europe, and to facilitate the sharing of information and resources. This work highlights the radiobiological capabilities of the INSPIRE partners, providing details of physics (available particle types and energies), biology (sample preparation and post-irradiation analysis), and researcher access (the process of applying for beam time). The collection of information reported here is designed to provide researchers both in Europe and worldwide with the tools required to select the optimal center for their research needs. We also highlight areas of redundancy in capabilities and suggest areas for future investment.
△ Less
Submitted 7 July, 2020;
originally announced July 2020.
-
The Laser-hybrid Accelerator for Radiobiological Applications
Authors:
G. Aymar,
T. Becker,
S. Boogert,
M. Borghesi,
R. Bingham,
C. Brenner,
P. N. Burrows,
T. Dascalu,
O. C. Ettlinger,
S. Gibson,
T. Greenshaw,
S. Gruber,
D. Gujral,
C. Hardiman,
J. Hughes,
W. G. Jones,
K. Kirkby,
A. Kurup,
J-B. Lagrange,
K. Long,
W. Luk,
J. Matheson,
P. McKenna,
R. Mclauchlan,
Z. Najmudin
, et al. (15 additional authors not shown)
Abstract:
The `Laser-hybrid Accelerator for Radiobiological Applications', LhARA, is conceived as a novel, uniquely-flexible facility dedicated to the study of radiobiology. The technologies demonstrated in LhARA, which have wide application, will be developed to allow particle-beam therapy to be delivered in a completely new regime, combining a variety of ion species in a single treatment fraction and expl…
▽ More
The `Laser-hybrid Accelerator for Radiobiological Applications', LhARA, is conceived as a novel, uniquely-flexible facility dedicated to the study of radiobiology. The technologies demonstrated in LhARA, which have wide application, will be developed to allow particle-beam therapy to be delivered in a completely new regime, combining a variety of ion species in a single treatment fraction and exploiting ultra-high dose rates. LhARA will be a hybrid accelerator system in which laser interactions drive the creation of a large flux of protons or light ions that are captured using a plasma (Gabor) lens and formed into a beam. The laser-driven source allows protons and ions to be captured at energies significantly above those that pertain in conventional facilities, thus evading the current space-charge limit on the instantaneous dose rate that can be delivered. The laser-hybrid approach, therefore, will allow the vast ``terra incognita'' of the radiobiology that determines the response of tissue to ionising radiation to be studied with protons and light ions using a wide variety of time structures, spectral distributions, and spatial configurations at instantaneous dose rates up to and significantly beyond the ultra-high dose-rate `FLASH' regime.
It is proposed that LhARA be developed in two stages. In the first stage, a programme of in vitro radiobiology will be served with proton beams with energies between 10MeV and 15MeV. In stage two, the beam will be accelerated using a fixed-field accelerator (FFA). This will allow experiments to be carried out in vitro and in vivo with proton beam energies of up to 127MeV. In addition, ion beams with energies up to 33.4MeV per nucleon will be available for in vitro and in vivo experiments. This paper presents the conceptual design for LhARA and the R&D programme by which the LhARA consortium seeks to establish the facility.
△ Less
Submitted 31 May, 2020;
originally announced June 2020.
